Wei-Qiang Gao

25PUBLICATIONS
46CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 27, 2026
NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.

Wei Zhang, Wenxin Feng, Chunxiao Ma

|Feb 26, 2026
Histone 3 lysine 36 trimethylation by SETD2 shapes an epigenetic landscape in intestinal stem cells to orchestrate lipid metabolism and attenuate cell senescence.

Yue Xu, Ziyi Wang, Wenxin Feng

|Jul 22, 2025
NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin/FAK/AKT signaling.

Wenxin Feng, Ningyuan Liu, Changwei Liu

|Mar 18, 2025
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway.

Jinming Wang, Penghui Xu, Zhongzhong Ji

|May 25, 2024
Region-Specific CD16+ Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells.

Yan Zhang, Zien Wang, Yu Lu

|Apr 23, 2024
Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.

Deng Wang, Genyu Du, Xinyu Chen

Pageof 5

Frequent Collaborators

9 joint publications

Helen He Zhu

5 joint publications

Li Li

3 joint publications

Pengcheng Zhang

2 joint publications

Xianting Ding